New

T-cell Therapy Market

2021

T-cell Therapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Modality- (Research, Commercialized); Therapy Type (CAR T-cell Therapy, T Cell Receptor (TCR)-based, Tumor Infiltrating Lymphocytes (TIL)-based); Indication (Hematologic Malignancies, Solid Tumors, Others) and Geography

| Report Code: TIPRE00024331 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

T-cell Therapy Market 2028 By Modality-, Therapy Type -based, Indication and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

T-cell therapy is a type of immunotherapy that utilizes specially altered T cells, i.e., a part of the immune system, in order to fight cancer. It is a type of treatment in which the sample of a patient's T cells is collected from the blood; then it is changed & modified in the laboratory to produce special structures called chimeric antigen receptors (CARs) on their surface in order to attack cancer cells. The CAR T cells are grown and given to the patient by infusion. This therapy is used to treat blood cancers and is approved for patients with relapsed or refractory acute lymphoblastic leukemia. The study for using this therapy for the treatment of other types of cancer is still going on.

MARKET SCOPE

The "Global T-cell Therapy Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the T-cell therapy market with detailed market segmentation by modality, therapy type, indication, and geography. The report provides key statistics on the market status of the leading T-cell therapy market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •  Based on modality, the global T-cell therapy market is segmented into research and commercialized.
  •  Based on therapy type, the market is segmented into CAR T-cell therapy, T cell receptor (TCR)-based and tumor infiltrating lymphocytes (TIL)-based.
  •  On the basis of indication, the market is bifurcated into hematologic malignancies, solid tumors and others.

MARKET DYNAMICS
Drivers:

  •  Increase in the number of cancer patients.
  •  Rise in the investment in adoptive T cell transfer approaches of disease treatment.
  •  Increase in the approval of T-cell therapy across various countries.
  •  Rise in developments associated with CAR T-cell therapy for solid tumors.
  •  Technological advancements in the T-cell manufacturing process.

Restraints:

  •  Regulatory and ethical challenges associated with gene therapy.
  •  High prices of therapies.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The T-cell therapy market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the T-cell therapy market in these regions.

IMPACT OF COVID-19ON T-CELL THERAPY MARKET

COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The pandemic has triggered new research opportunities for market players to invest in T-cell therapies for viral infection. The scientific community is actively engaged in finding the potential for T-cell therapy to treat high-risk COVID-19 patients, resulting in increased adoption of T-cell therapeutics and thus supplement the market growth. Moreover, due to disruptions caused across the supply chain, several market players are adopting digital alternatives to manage the cell therapy supply chain, which is anticipated to increase the market growth. Hence, owing to the above-mentioned factors, the market demand was positively affected during the pandemic era.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the T-cell therapy market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from T-cell therapy market are anticipated to have lucrative growth opportunities in the future with the rising demand for T-cell therapy in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the T-cell therapy market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •  Novartis AG
  •  Pfizer Inc.
  •  Merck KGaA
  •  Bluebird Bio Inc.
  •  Celgene Corporation
  •  Gilead Sciences Inc.
  •  Amgen
  •  Adaptimmune
  •  Sorrento Therapeutics
  •  TCR2 Therapeutics Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 T-cell Therapy Market - By Modality-
1.3.2 T-cell Therapy Market - By Therapy Type
1.3.3 T-cell Therapy Market - By Indication
1.3.4 T-cell Therapy Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. T-CELL THERAPY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS

5. T-CELL THERAPY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. T-CELL THERAPY MARKET - GLOBAL MARKET ANALYSIS
6.1. T-CELL THERAPY - GLOBAL MARKET OVERVIEW
6.2. T-CELL THERAPY - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. T-CELL THERAPY MARKET - REVENUE AND FORECASTS TO 2028 - MODALITY-
7.1. OVERVIEW
7.2. MODALITY- MARKET FORECASTS AND ANALYSIS
7.3. RESEARCH
7.3.1. Overview
7.3.2. Research Market Forecast and Analysis
7.4. COMMERCIALIZED
7.4.1. Overview
7.4.2. Commercialized Market Forecast and Analysis
8. T-CELL THERAPY MARKET - REVENUE AND FORECASTS TO 2028 - THERAPY TYPE
8.1. OVERVIEW
8.2. THERAPY TYPE MARKET FORECASTS AND ANALYSIS
8.3. CAR T-CELL THERAPY
8.3.1. Overview
8.3.2. CAR T-cell Therapy Market Forecast and Analysis
8.4. T CELL RECEPTOR (TCR)-BASED
8.4.1. Overview
8.4.2. T Cell Receptor (TCR)-based Market Forecast and Analysis
8.5. TUMOR INFILTRATING LYMPHOCYTES (TIL)-BASED
8.5.1. Overview
8.5.2. Tumor Infiltrating Lymphocytes (TIL)-based Market Forecast and Analysis
9. T-CELL THERAPY MARKET - REVENUE AND FORECASTS TO 2028 - INDICATION
9.1. OVERVIEW
9.2. INDICATION MARKET FORECASTS AND ANALYSIS
9.3. HEMATOLOGIC MALIGNANCIES
9.3.1. Overview
9.3.2. Hematologic Malignancies Market Forecast and Analysis
9.3.3. Lymphoma Market
9.3.3.1. Overview
9.3.3.2. Lymphoma Market Forecast and Analysis
9.3.4. Leukemia Market
9.3.4.1. Overview
9.3.4.2. Leukemia Market Forecast and Analysis
9.3.5. Myeloma Market
9.3.5.1. Overview
9.3.5.2. Myeloma Market Forecast and Analysis
9.4. SOLID TUMORS
9.4.1. Overview
9.4.2. Solid Tumors Market Forecast and Analysis
9.4.3. Melanoma Market
9.4.3.1. Overview
9.4.3.2. Melanoma Market Forecast and Analysis
9.4.4. Brain and Central Nervous System Market
9.4.4.1. Overview
9.4.4.2. Brain and Central Nervous System Market Forecast and Analysis
9.4.5. Liver Cancer Market
9.4.5.1. Overview
9.4.5.2. Liver Cancer Market Forecast and Analysis
9.4.6. Others Market
9.4.6.1. Overview
9.4.6.2. Others Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis

10. T-CELL THERAPY MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America T-cell Therapy Market Overview
10.1.2 North America T-cell Therapy Market Forecasts and Analysis
10.1.3 North America T-cell Therapy Market Forecasts and Analysis - By Modality-
10.1.4 North America T-cell Therapy Market Forecasts and Analysis - By Therapy Type
10.1.5 North America T-cell Therapy Market Forecasts and Analysis - By Indication
10.1.6 North America T-cell Therapy Market Forecasts and Analysis - By Countries
10.1.6.1 United States T-cell Therapy Market
10.1.6.1.1 United States T-cell Therapy Market by Modality-
10.1.6.1.2 United States T-cell Therapy Market by Therapy Type
10.1.6.1.3 United States T-cell Therapy Market by Indication
10.1.6.2 Canada T-cell Therapy Market
10.1.6.2.1 Canada T-cell Therapy Market by Modality-
10.1.6.2.2 Canada T-cell Therapy Market by Therapy Type
10.1.6.2.3 Canada T-cell Therapy Market by Indication
10.1.6.3 Mexico T-cell Therapy Market
10.1.6.3.1 Mexico T-cell Therapy Market by Modality-
10.1.6.3.2 Mexico T-cell Therapy Market by Therapy Type
10.1.6.3.3 Mexico T-cell Therapy Market by Indication
10.2. EUROPE
10.2.1 Europe T-cell Therapy Market Overview
10.2.2 Europe T-cell Therapy Market Forecasts and Analysis
10.2.3 Europe T-cell Therapy Market Forecasts and Analysis - By Modality-
10.2.4 Europe T-cell Therapy Market Forecasts and Analysis - By Therapy Type
10.2.5 Europe T-cell Therapy Market Forecasts and Analysis - By Indication
10.2.6 Europe T-cell Therapy Market Forecasts and Analysis - By Countries
10.2.6.1 Germany T-cell Therapy Market
10.2.6.1.1 Germany T-cell Therapy Market by Modality-
10.2.6.1.2 Germany T-cell Therapy Market by Therapy Type
10.2.6.1.3 Germany T-cell Therapy Market by Indication
10.2.6.2 France T-cell Therapy Market
10.2.6.2.1 France T-cell Therapy Market by Modality-
10.2.6.2.2 France T-cell Therapy Market by Therapy Type
10.2.6.2.3 France T-cell Therapy Market by Indication
10.2.6.3 Italy T-cell Therapy Market
10.2.6.3.1 Italy T-cell Therapy Market by Modality-
10.2.6.3.2 Italy T-cell Therapy Market by Therapy Type
10.2.6.3.3 Italy T-cell Therapy Market by Indication
10.2.6.4 Spain T-cell Therapy Market
10.2.6.4.1 Spain T-cell Therapy Market by Modality-
10.2.6.4.2 Spain T-cell Therapy Market by Therapy Type
10.2.6.4.3 Spain T-cell Therapy Market by Indication
10.2.6.5 United Kingdom T-cell Therapy Market
10.2.6.5.1 United Kingdom T-cell Therapy Market by Modality-
10.2.6.5.2 United Kingdom T-cell Therapy Market by Therapy Type
10.2.6.5.3 United Kingdom T-cell Therapy Market by Indication
10.2.6.6 Rest of Europe T-cell Therapy Market
10.2.6.6.1 Rest of Europe T-cell Therapy Market by Modality-
10.2.6.6.2 Rest of Europe T-cell Therapy Market by Therapy Type
10.2.6.6.3 Rest of Europe T-cell Therapy Market by Indication
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific T-cell Therapy Market Overview
10.3.2 Asia-Pacific T-cell Therapy Market Forecasts and Analysis
10.3.3 Asia-Pacific T-cell Therapy Market Forecasts and Analysis - By Modality-
10.3.4 Asia-Pacific T-cell Therapy Market Forecasts and Analysis - By Therapy Type
10.3.5 Asia-Pacific T-cell Therapy Market Forecasts and Analysis - By Indication
10.3.6 Asia-Pacific T-cell Therapy Market Forecasts and Analysis - By Countries
10.3.6.1 Australia T-cell Therapy Market
10.3.6.1.1 Australia T-cell Therapy Market by Modality-
10.3.6.1.2 Australia T-cell Therapy Market by Therapy Type
10.3.6.1.3 Australia T-cell Therapy Market by Indication
10.3.6.2 China T-cell Therapy Market
10.3.6.2.1 China T-cell Therapy Market by Modality-
10.3.6.2.2 China T-cell Therapy Market by Therapy Type
10.3.6.2.3 China T-cell Therapy Market by Indication
10.3.6.3 India T-cell Therapy Market
10.3.6.3.1 India T-cell Therapy Market by Modality-
10.3.6.3.2 India T-cell Therapy Market by Therapy Type
10.3.6.3.3 India T-cell Therapy Market by Indication
10.3.6.4 Japan T-cell Therapy Market
10.3.6.4.1 Japan T-cell Therapy Market by Modality-
10.3.6.4.2 Japan T-cell Therapy Market by Therapy Type
10.3.6.4.3 Japan T-cell Therapy Market by Indication
10.3.6.5 South Korea T-cell Therapy Market
10.3.6.5.1 South Korea T-cell Therapy Market by Modality-
10.3.6.5.2 South Korea T-cell Therapy Market by Therapy Type
10.3.6.5.3 South Korea T-cell Therapy Market by Indication
10.3.6.6 Rest of Asia-Pacific T-cell Therapy Market
10.3.6.6.1 Rest of Asia-Pacific T-cell Therapy Market by Modality-
10.3.6.6.2 Rest of Asia-Pacific T-cell Therapy Market by Therapy Type
10.3.6.6.3 Rest of Asia-Pacific T-cell Therapy Market by Indication
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa T-cell Therapy Market Overview
10.4.2 Middle East and Africa T-cell Therapy Market Forecasts and Analysis
10.4.3 Middle East and Africa T-cell Therapy Market Forecasts and Analysis - By Modality-
10.4.4 Middle East and Africa T-cell Therapy Market Forecasts and Analysis - By Therapy Type
10.4.5 Middle East and Africa T-cell Therapy Market Forecasts and Analysis - By Indication
10.4.6 Middle East and Africa T-cell Therapy Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa T-cell Therapy Market
10.4.6.1.1 South Africa T-cell Therapy Market by Modality-
10.4.6.1.2 South Africa T-cell Therapy Market by Therapy Type
10.4.6.1.3 South Africa T-cell Therapy Market by Indication
10.4.6.2 Saudi Arabia T-cell Therapy Market
10.4.6.2.1 Saudi Arabia T-cell Therapy Market by Modality-
10.4.6.2.2 Saudi Arabia T-cell Therapy Market by Therapy Type
10.4.6.2.3 Saudi Arabia T-cell Therapy Market by Indication
10.4.6.3 U.A.E T-cell Therapy Market
10.4.6.3.1 U.A.E T-cell Therapy Market by Modality-
10.4.6.3.2 U.A.E T-cell Therapy Market by Therapy Type
10.4.6.3.3 U.A.E T-cell Therapy Market by Indication
10.4.6.4 Rest of Middle East and Africa T-cell Therapy Market
10.4.6.4.1 Rest of Middle East and Africa T-cell Therapy Market by Modality-
10.4.6.4.2 Rest of Middle East and Africa T-cell Therapy Market by Therapy Type
10.4.6.4.3 Rest of Middle East and Africa T-cell Therapy Market by Indication
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America T-cell Therapy Market Overview
10.5.2 South and Central America T-cell Therapy Market Forecasts and Analysis
10.5.3 South and Central America T-cell Therapy Market Forecasts and Analysis - By Modality-
10.5.4 South and Central America T-cell Therapy Market Forecasts and Analysis - By Therapy Type
10.5.5 South and Central America T-cell Therapy Market Forecasts and Analysis - By Indication
10.5.6 South and Central America T-cell Therapy Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil T-cell Therapy Market
10.5.6.1.1 Brazil T-cell Therapy Market by Modality-
10.5.6.1.2 Brazil T-cell Therapy Market by Therapy Type
10.5.6.1.3 Brazil T-cell Therapy Market by Indication
10.5.6.2 Argentina T-cell Therapy Market
10.5.6.2.1 Argentina T-cell Therapy Market by Modality-
10.5.6.2.2 Argentina T-cell Therapy Market by Therapy Type
10.5.6.2.3 Argentina T-cell Therapy Market by Indication
10.5.6.3 Rest of South and Central America T-cell Therapy Market
10.5.6.3.1 Rest of South and Central America T-cell Therapy Market by Modality-
10.5.6.3.2 Rest of South and Central America T-cell Therapy Market by Therapy Type
10.5.6.3.3 Rest of South and Central America T-cell Therapy Market by Indication

11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. T-CELL THERAPY MARKET, KEY COMPANY PROFILES
12.1. NOVARTIS AG
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. PFIZER INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. MERCK KGAA
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BLUEBIRD BIO INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. CELGENE CORPORATION
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. GILEAD SCIENCES INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. AMGEN
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. ADAPTIMMUNE
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SORRENTO THERAPEUTICS
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. TCR2 THERAPEUTICS INC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Novartis AG
2. Pfizer Inc.
3. Merck KGaA
4. Bluebird Bio Inc.
5. Celgene Corporation
6. Gilead Sciences Inc.
7. Amgen
8. Adaptimmune
9. Sorrento Therapeutics
10. TCR2 Therapeutics Inc
TIPRE00024331
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.